Heterogeneity evidence and linkage studies on Charcot‐Marie‐Tooth disease
- 1 February 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 39 (2) , 280
- https://doi.org/10.1212/wnl.39.2.280
Abstract
Charcot-Marie-Tooth neuropathy type 1 (CMT1) is an autosomal dominant disorder originally localized to chromosome 1 by linkage to the Duffy blood group. Studies have since shown that the disorder may be heterogeneous, as not all families show this linkage. We tested genetic heterogeneity by the HOMOG computer program in 15 CMT1 pedigrees informative for Duffy. We detected no evidence for heterogeneity in this sample, but when we combined results with previously published lod scores, heterogeneity was statistically significant. Twelve of the 15 families studied did not show linkage to Duffy. We found six of these families to be informative for a chromosome 19 marker, apolipoprotein CII (ApoC2). Despite a previous report showing probable linkage of a non-Duffy-linked CMT1 pedigree to two chromosome 19 markers, we did not detect significant linkage of ApoC2 to CMT1 in these families.This publication has 4 references indexed in Scilit:
- CHROMOSOME-I LINKAGE STUDIES IN CHARCOT-MARIE-TOOTH NEUROPATHY TYPE-I1988
- The apolipoprotein CII gene: Subchromosomal localisation and linkage to the myotonic dystrophy locusHuman Genetics, 1985
- Genetic linkage evidence for heterogeneity in Charcot‐Marie‐Tooth neuropathy (HMSN type I)Annals of Neurology, 1983
- EVIDENCE FOR LINKAGE OF CHARCOT-MARIE-TOOTH NEUROPATHY TO THE DUFFY LOCUS ON CHROMOSOME-11982